83_FR_16185 83 FR 16113 - National Institute on Minority Health and Health Disparities; Notice of Closed Meeting

83 FR 16113 - National Institute on Minority Health and Health Disparities; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 72 (April 13, 2018)

Page Range16113-16113
FR Document2018-07756

Federal Register, Volume 83 Issue 72 (Friday, April 13, 2018)
[Federal Register Volume 83, Number 72 (Friday, April 13, 2018)]
[Notices]
[Page 16113]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07756]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Minority Health and Health Disparities; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Minority Health and 
Health Disparities Special Emphasis Panel; Mechanisms of Disparities 
for HIV-Related Co-morbidities in Health Disparity Populations.
    Date: May 30, 2018.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Minority Health and Health 
Disparities, 7201 Wisconsin Ave., Suite 525, Rm. 533K, Bethesda, MD 
20814 (Telephone Conference Call).
    Contact Person: Xinli Nan, Ph.D., Scientific Review Officer, 
National Institute on Minority Health and Health Disparities, 
National Institutes of Health, Scientific Review Branch, OERA, 7201 
Wisconsin Ave., Suite 525, Bethesda, MD 20814, (301) 594-7784, 
Xinli.Nan@nih.gov.


    Dated: April 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07756 Filed 4-12-18; 8:45 am]
 BILLING CODE 4140-01-P



                                                                                Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices                                                16113

                                               government-issued photo ID, driver’s license,           Review Branch, OERA, 7201 Wisconsin Ave.,             (Catalogue of Federal Domestic Assistance
                                               or passport) and to state the purpose of their          Suite 525, Bethesda, MD 20814, (301) 594–             Program No.: 93.279, Drug Abuse and
                                               visit.                                                  7784, Xinli.Nan@nih.gov.                              Addiction Research Programs, National
                                                  Information is also available on the                                                                       Institutes of Health, HHS)
                                               Council of Council’s home page at http://                 Dated: April 10, 2018.
                                                                                                                                                               Dated: April 10, 2018.
                                               dpcpsi.nih.gov/council/ where an agenda                 David D. Clary,
                                               will be posted before the meeting date.                                                                       Natasha M. Copeland,
                                                                                                       Program Analyst, Office of Federal Advisory
                                               (Catalogue of Federal Domestic Assistance               Committee Policy.                                     Program Analyst, Office of Federal Advisory
                                               Program Nos. 93.14, Intramural Research                                                                       Committee Policy.
                                                                                                       [FR Doc. 2018–07756 Filed 4–12–18; 8:45 am]
                                               Training Award; 93.22, Clinical Research                                                                      [FR Doc. 2018–07754 Filed 4–12–18; 8:45 am]
                                                                                                       BILLING CODE 4140–01–P
                                               Loan Repayment Program for Individuals                                                                        BILLING CODE 4140–01–P
                                               from Disadvantaged Backgrounds; 93.232,
                                               Loan Repayment Program for Research
                                               Generally; 93.39, Academic Research                     DEPARTMENT OF HEALTH AND
                                                                                                       HUMAN SERVICES                                        DEPARTMENT OF HEALTH AND
                                               Enhancement Award; 93.936, NIH Acquired
                                                                                                                                                             HUMAN SERVICES
                                               Immunodeficiency Syndrome Research Loan
                                               Repayment Program; 93.187, Undergraduate                National Institutes of Health
                                                                                                                                                             National Institutes of Health
                                               Scholarship Program for Individuals from
                                               Disadvantaged Backgrounds, National                     National Institute on Drug Abuse;
                                                                                                       Notice of Closed Meetings                             Center for Scientific Review; Notice of
                                               Institutes of Health, HHS)
                                                                                                                                                             Closed Meetings
                                                 Dated: April 10, 2018.                                  Pursuant to section 10(d) of the
                                               David D. Clary,                                         Federal Advisory Committee Act, as                      Pursuant to section 10(d) of the
                                               Program Analyst, Office of Federal Advisory             amended, notice is hereby given of the                Federal Advisory Committee Act, as
                                               Committee Policy.                                       following meetings.                                   amended, notice is hereby given of the
                                               [FR Doc. 2018–07757 Filed 4–12–18; 8:45 am]               The meetings will be closed to the                  following meetings.
                                                                                                       public in accordance with the                           The meetings will be closed to the
                                               BILLING CODE 4140–01–P
                                                                                                       provisions set forth in sections                      public in accordance with the
                                                                                                       552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            provisions set forth in sections
                                               DEPARTMENT OF HEALTH AND                                as amended. The contract proposals and                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                               HUMAN SERVICES                                          the discussions could disclose                        as amended. The grant applications and
                                                                                                       confidential trade secrets or commercial              the discussions could disclose
                                               National Institutes of Health                           property such as patentable material,                 confidential trade secrets or commercial
                                                                                                       and personal information concerning                   property such as patentable material,
                                               National Institute on Minority Health                   individuals associated with the contract              and personal information concerning
                                               and Health Disparities; Notice of                       proposals, the disclosure of which                    individuals associated with the grant
                                               Closed Meeting                                          would constitute a clearly unwarranted                applications, the disclosure of which
                                                                                                       invasion of personal privacy.                         would constitute a clearly unwarranted
                                                 Pursuant to section 10(d) of the
                                                                                                                                                             invasion of personal privacy.
                                               Federal Advisory Committee Act, as                        Name of Committee: National Institute on
                                               amended, notice is hereby given of the                  Drug Abuse Special Emphasis Panel;                      Name of Committee: Center for Scientific
                                               following meeting.                                      Synthesis and Distribution of Drugs of Abuse          Review Special Emphasis Panel; Chronic
                                                 The meeting will be closed to the                     and Related Compounds (8944).                         Disease in the Caribbean-II.
                                               public in accordance with the                             Date: April 24, 2018.                                 Date: April 16, 2018.
                                                                                                         Time: 10:00 a.m. to 1:00 p.m.                         Time: 3:00 p.m. to 3:30 p.m.
                                               provisions set forth in sections                                                                                Agenda: To review and evaluate grant
                                                                                                         Agenda: To review and evaluate contract
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              proposals.                                            applications.
                                               as amended. The grant applications and                    Place: National Institutes of Health,                 Place: National Institutes of Health, 6701
                                               the discussions could disclose                          Neuroscience Center, 6001 Executive                   Rockledge Drive, Bethesda, MD 20892
                                               confidential trade secrets or commercial                Boulevard, Rockville, MD 20852 (Telephone             (Telephone Conference Call).
                                               property such as patentable materials,                  Conference Call).                                       Contact Person: Gniesha Yvonne
                                               and personal information concerning                       Contact Person: Lyle Furr, Scientific               Dinwiddie, Ph.D., Scientific Review Officer,
                                               individuals associated with the grant                   Review Officer, Office of Extramural Affairs,         Center for Scientific Review, National
                                               applications, the disclosure of which                   National Institute on Drug Abuse, NIH,                Institutes of Health, 6701 Rockledge Drive,
                                                                                                       DHHS, Room 4227, MSC 9550, 6001                       Room 3137, Bethesda, MD 20892,
                                               would constitute a clearly unwarranted                  Executive Boulevard, Bethesda, MD 20892–              dinwiddiegy@csr.nih.gov.
                                               invasion of personal privacy.                           9550, (301) 827–5702, lf33c.nih.gov.                    This notice is being published less
                                                 Name of Committee: National Institute on                Name of Committee: National Institute on            than 15 days prior to the meeting due
                                               Minority Health and Health Disparities                  Drug Abuse Special Emphasis Panel;                    to the timing limitations imposed by the
                                               Special Emphasis Panel; Mechanisms of                   Toxicological Evaluations of Potential
                                               Disparities for HIV-Related Co-morbidities in
                                                                                                                                                             review and funding cycle.
                                                                                                       Medications to Treat Drug Addiction (8939).
                                               Health Disparity Populations.                             Date: May 15, 2018.                                   Name of Committee: Center for Scientific
                                                 Date: May 30, 2018.                                     Time: 10:00 a.m. to 1:00 p.m.                       Review Special Emphasis Panel; AIDS and
                                                 Time: 12:00 p.m. to 5:00 p.m.                           Agenda: To review and evaluate contract             Related Research Special Topic.
                                                 Agenda: To review and evaluate grant                  proposals.                                              Date: April 19, 2018.
                                               applications.                                             Place: National Institutes of Health,                 Time: 11:00 a.m. to 1:00 p.m.
                                                 Place: National Institute on Minority                 Neuroscience Center, 6001 Executive                     Agenda: To review and evaluate grant
daltland on DSKBBV9HB2PROD with NOTICES




                                               Health and Health Disparities, 7201                     Boulevard, Rockville, MD 20852 (Telephone             applications.
                                               Wisconsin Ave., Suite 525, Rm. 533K,                    Conference Call).                                       Place: National Institutes of Health, 6701
                                               Bethesda, MD 20814 (Telephone Conference                  Contact Person: Lyle Furr, Scientific               Rockledge Drive, Bethesda, MD 20892
                                               Call).                                                  Review Officer, Office of Extramural Affairs,         (Telephone Conference Call).
                                                 Contact Person: Xinli Nan, Ph.D., Scientific          National Institute on Drug Abuse, NIH,                  Contact Person: Robert Freund, Ph.D.,
                                               Review Officer, National Institute on                   DHHS, Room 4227, MSC 9550, 6001                       Scientific Review Officer, Center for
                                               Minority Health and Health Disparities,                 Executive Boulevard, Bethesda, MD 20892–              Scientific Review, National Institutes of
                                               National Institutes of Health, Scientific               9550, (301) 827–5702, lf33c.nih.gov.                  Health, 6701 Rockledge Drive, Room 5216,



                                          VerDate Sep<11>2014   19:04 Apr 12, 2018   Jkt 244001   PO 00000   Frm 00070   Fmt 4703   Sfmt 4703   E:\FR\FM\13APN1.SGM   13APN1



Document Created: 2018-04-13 00:18:16
Document Modified: 2018-04-13 00:18:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 30, 2018.
FR Citation83 FR 16113 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR